Back to Search Start Over

A rapid review of patient-reported outcomes investigated in the context of advanced renal cell cancer or advanced hepatocellular cancer.

Authors :
Diez de los Rios de la Serna, Celia
Kotronoulas, Grigorios
Drury, Amanda
Oldenmenger, Wendy
Kelly, Daniel
Source :
European Journal of Oncology Nursing; Apr2023, Vol. 63, pN.PAG-N.PAG, 1p
Publication Year :
2023

Abstract

Patient-reported outcomes (PROs) are key indicators of health status and functioning, coming directly from the patient. Comprehensive monitoring of PROs enables implementation of person-centred care. Currently, the PROs that patients with advanced renal cell carcinoma (RCC) or hepatocellular carcinoma (HCC) consider of greatest importance remains unknown. A rapid literature review was carried out to identify PROs commonly reported in clinical studies of patients with advanced RCC/HCC. We searched MEDLINE, CINAHL & PsycInfo for relevant peer-reviewed publications in the period from 2000 to 2021. Pre-specified selection criteria were applied to all retrieved records. Findings were integrated into a narrative synthesis. Eighty-one studies met our selection criteria and were retained. Most research was on advanced RCC (n = 64, 79%); 46 studies (57%) were drug trials. Only twenty-six studies (32%) employed PROs as their primary endpoint. Most PROs concerned physical symptoms (45% RCC, 54% HCC) and emotional wellbeing (19% RCC, 16% HCC). The most common outcome measured was quality of life (65% of the total), followed by fatigue (62%) and pain (54%). Whether selection of these PROs was patient-driven was not reported. A wide range of PROs were assessed. Deficits in PROs often cause patients to seek out help; however, which PROs matter the most to people with advanced RCC/HCC must be further clarified. Targeting, monitoring, and responding to the 'right' PROs can enhance provision of person-centred care in advanced RCC/HCC and augment the clinical efficacy of established and emerging targeted therapies. • We explored what PROs are commonly reported in advanced renal or liver cancer. • Quality of life and physical symptoms were the most frequently assessed PROs. • Whether selection of these PROs was patient-driven was not reported. • Clinicians must address the 'right' PROs for person-centred care to be enhanced. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
14623889
Volume :
63
Database :
Supplemental Index
Journal :
European Journal of Oncology Nursing
Publication Type :
Academic Journal
Accession number :
162892170
Full Text :
https://doi.org/10.1016/j.ejon.2022.102241